These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 22667764)

  • 1. Association of angiotensin I converting enzyme polymorphism as genetic risk factor in benign prostatic hyperplasia and prostate cancer.
    Hasanzad M; Samzadeh M; Jamaldini SH; Haghdoost AA; Afshari M; Ziaei SA
    Genet Test Mol Biomarkers; 2012 Jul; 16(7):770-4. PubMed ID: 22667764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin-converting enzyme insertion/deletion and angiotensin type 1 receptor A1166C polymorphisms as genetic risk factors in benign prostatic hyperplasia and prostate cancer.
    Sierra Díaz E; Sánchez Corona J; Rosales Gómez RC; Gutierrez Rubio SA; Vázquez Camacho JG; Solano Moreno H; Morán Moguel MC
    J Renin Angiotensin Aldosterone Syst; 2009 Dec; 10(4):241-6. PubMed ID: 20026870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of ACE I/D polymorphism on prostate cancer risk, tumor grade and metastatis.
    Yigit B; Bozkurt N; Narter F; Yilmaz H; Yucebas E; Isbir T
    Anticancer Res; 2007; 27(2):933-6. PubMed ID: 17465223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linkage of angiotensin I-converting enzyme gene insertion/deletion polymorphism to the progression of human prostate cancer.
    Medeiros R; Vasconcelos A; Costa S; Pinto D; Lobo F; Morais A; Oliveira J; Lopes C
    J Pathol; 2004 Mar; 202(3):330-5. PubMed ID: 14991898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-converting enzyme insertion/deletion polymorphism and the risk of prostate cancer in the Han population of China.
    Wang X; Wang S; Lin YW; Wu J; Chen H; Mao YQ; Zheng XY; Zhou C; Xie LP
    Med Oncol; 2012 Sep; 29(3):1964-71. PubMed ID: 21874567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion polymorphism in the angiotensin-converting enzyme gene as a thrombophilic risk factor after hip arthroplasty.
    Philipp CS; Dilley A; Saidi P; Evatt B; Austin H; Zawadsky J; Harwood D; Ellingsen D; Barnhart E; Phillips DJ; Hooper WC
    Thromb Haemost; 1998 Dec; 80(6):869-73. PubMed ID: 9869151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of G/A polymorphism, rs266882, in AREI region of the prostate-specific antigen gene with prostate cancer risk and clinicopathological features.
    Samzadeh M; Hasanzad M; Jamaldini SH; Haghdoost AA; Afshari M; Ziaee SA
    Urol J; 2012; 9(4):691-9. PubMed ID: 23235975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of angiotensin I converting enzyme insertion/deletion polymorphism with breast cancer: a meta-analysis.
    Sun M; Liu C; Wei F; Zhong J; Sun Y
    J Renin Angiotensin Aldosterone Syst; 2011 Dec; 12(4):611-6. PubMed ID: 21546404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between angiotensin-converting enzyme insertion/deletion genetic polymorphism and hypertension in a sample of Lebanese patients.
    Akra-Ismail M; Makki RF; Chmaisse HN; Kazma A; Zgheib NK
    Genet Test Mol Biomarkers; 2010 Dec; 14(6):787-92. PubMed ID: 20939740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-converting enzyme insertion/deletion gene polymorphism in a Tunisian healthy and acute myocardial infarction population.
    Mehri S; Baudin B; Mahjoub S; Zaroui A; Bénéteau-Burnat B; Mechmeche R; Hammami M; Ben Arab S
    Genet Test Mol Biomarkers; 2010 Feb; 14(1):85-91. PubMed ID: 20059382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between angiotensin-converting enzyme insertion/deletion gene polymorphism and prostate cancer susceptibility.
    Wang ZY; Li HY; Jiang ZP; Zhou TB
    J Cancer Res Ther; 2018 Jun; 14(Supplement):S375-S380. PubMed ID: 29970692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of and prognosis after myocardial infarction.
    Samani NJ; O'Toole L; Martin D; Rai H; Fletcher S; Lodwick D; Thompson JR; Morice AH; Channer K; Woods KL
    J Am Coll Cardiol; 1996 Aug; 28(2):338-44. PubMed ID: 8800107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of a common genetic variant (insertion/deletion) in ACE gene with prostate cancer susceptibility in a Tunisian population.
    Said R; Jenni R; Boussetta S; Ammous F; Zouari S; Zaghbib S; Chakroun M; Derouiche A; Chebil M; Ouerhani S
    J Clin Lab Anal; 2022 Jan; 36(1):e24129. PubMed ID: 34799866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme polymorphism and erectile dysfunction complaints in the Brazilian population.
    Andersen ML; Guindalini C; Santos-Silva R; Bittencourt LR; Tufik S
    J Sex Med; 2010 Aug; 7(8):2791-7. PubMed ID: 20384940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renin angiotensin system blockage associates with insertion/deletion polymorphism of angiotensin-converting enzyme in patients with hypertensive emergency.
    Vilela-Martin JF; Vaz-de-Melo RO; Cosenso-Martin LN; Kuniyoshi CH; Yugar-Toledo JC; Pinhel MA; de Souza GF; Souza DR; Pimenta E; Moreno H; Cipullo JP
    DNA Cell Biol; 2013 Sep; 32(9):541-8. PubMed ID: 23869738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of association between ACE insertion/deletion polymorphism and lung cancer: A meta-analysis.
    Cheng Z; Ma R; Tan W; Zhang L; Tan Q
    J Renin Angiotensin Aldosterone Syst; 2015 Jun; 16(2):453-8. PubMed ID: 25092717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microsatellite polymorphism of steroid hormone synthesis gene CYP11A1 is associated with advanced prostate cancer.
    Kumazawa T; Tsuchiya N; Wang L; Sato K; Kamoto T; Ogawa O; Nakamura A; Kato T; Habuchi T
    Int J Cancer; 2004 May; 110(1):140-4. PubMed ID: 15054879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with increased risk for oral cancer.
    Vairaktaris E; Yapijakis C; Tsigris C; Vassiliou S; Derka S; Nkenke E; Spyridonidou S; Vylliotis A; Vorris E; Ragos V; Neukam FW; Patsouris E
    Acta Oncol; 2007; 46(8):1097-102. PubMed ID: 17851834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Angiotensin-converting enyme insertion/deletion polymorphism and blood pressure regulation in type 2 diabetic patients].
    Krajina-Andricević M; Zibar L; Glavas-Obrovac- L; Stefanić M; Avdicević M; Barbić J
    Acta Med Croatica; 2011 Oct; 65 Suppl 3():14-9. PubMed ID: 23120809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The angiotensin-converting enzyme insertion/deletion polymorphism and serum levels of angiotensin-converting enzyme in venous thromboembolism. Data from a case control study.
    Ay C; Bencur P; Vormittag R; Sailer T; Jungbauer C; Vukovich T; Mannhalter C; Pabinger I
    Thromb Haemost; 2007 Oct; 98(4):777-82. PubMed ID: 17938801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.